AngioDynamics, Inc. Payments for Restructuring
AngioDynamics, Inc. (ANGO) reported Payments for Restructuring of $11.96 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-07-14
- AngioDynamics, Inc. payments for restructuring for the quarter ending 2026-05-31 was $2.80M, a 4.07% decline year-over-year.
- AngioDynamics, Inc. payments for restructuring for the quarter ending 2026-02-28 was $5.30M, a 49.27% increase year-over-year.
- AngioDynamics, Inc. payments for restructuring for the quarter ending 2025-11-30 was $1.59M, a 40.80% decline year-over-year.
- AngioDynamics, Inc. payments for restructuring for the quarter ending 2025-08-31 was $2.26M, a 23.32% increase year-over-year.
- AngioDynamics, Inc. payments for restructuring for fiscal 2026 was $11.96M, a 8.75% increase from fiscal 2025.
- AngioDynamics, Inc. payments for restructuring for fiscal 2025 was $11.00M.
- AngioDynamics, Inc. payments for restructuring for fiscal 2020 was $38.00K, a 97.16% decline from fiscal 2019.
- AngioDynamics, Inc. payments for restructuring for fiscal 2019 was $1.34M, a 68.80% decline from fiscal 2018.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2026-05-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $8.10M derived: sum of 2 quarters · filed 2026-07-14 | $9.70M derived: sum of 3 quarters · filed 2026-07-14 | $11.96M 10-K · filed 2026-07-14 |
| 2026-02-28 | $5.30M 10-Q · filed 2026-04-02 | $6.89M derived: sum of 2 quarters · filed 2026-04-02 | $9.15M 10-Q · filed 2026-04-02 | $12.08M derived: sum of 4 quarters · filed 2026-04-02 |
| 2025-11-30 | $1.59M 10-Q · filed 2026-01-06 | $3.86M 10-Q · filed 2026-01-06 | $6.78M derived: sum of 3 quarters · filed 2026-01-06 | $10.33M derived: sum of 4 quarters · filed 2026-01-06 |
| 2025-08-31 | $2.26M 10-Q · filed 2025-10-02 | $5.19M derived: sum of 2 quarters · filed 2025-10-02 | $8.74M derived: sum of 3 quarters · filed 2025-10-02 | $11.43M derived: sum of 4 quarters · filed 2025-10-02 |
| 2025-05-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $6.47M derived: sum of 2 quarters · filed 2025-07-18 | $9.16M derived: sum of 3 quarters · filed 2025-07-18 | $11.00M 10-K · filed 2025-07-18 |
| 2025-02-28 | $3.55M 10-Q · filed 2025-04-02 | $6.24M derived: sum of 2 quarters · filed 2025-04-02 | $8.07M 10-Q · filed 2025-04-02 | $9.67M derived: sum of 4 quarters · filed 2025-04-02 |
| 2024-11-30 | $2.69M 10-Q · filed 2025-01-08 | $4.53M 10-Q · filed 2025-01-08 | $6.12M derived: sum of 3 quarters · filed 2025-01-08 | $6.80M derived: sum of 4 quarters · filed 2025-01-08 |
| 2024-08-31 | $1.83M 10-Q · filed 2024-10-03 | $3.43M derived: sum of 2 quarters · filed 2024-10-03 | $4.11M derived: sum of 3 quarters · filed 2024-10-03 | |
| 2024-05-31 | $1.59M 10-K · filed 2024-07-25 | $2.27M derived: sum of 2 quarters · filed 2024-07-25 | ||
| 2024-02-29 | $676.00K 10-Q · filed 2024-04-09 | $676.00K 10-Q · filed 2024-04-09 | ||
| 2020-05-31 | $38.00K 10-K · filed 2020-08-10 | |||
| 2019-05-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $312.00K derived: sum of 2 quarters · filed 2020-08-10 | $687.00K derived: sum of 3 quarters · filed 2020-08-10 | $1.34M 10-K · filed 2020-08-10 |
| 2019-02-28 | $292.00K 10-Q · filed 2019-04-02 | $667.00K derived: sum of 2 quarters · filed 2019-04-02 | $1.32M 10-Q · filed 2019-04-02 | $2.44M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-11-30 | $375.00K 10-Q · filed 2019-01-07 | $1.03M 10-Q · filed 2019-01-07 | $2.15M derived: sum of 3 quarters · filed 2020-08-10 | $3.86M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-08-31 | $653.00K 10-Q · filed 2018-10-01 | $1.78M derived: sum of 2 quarters · filed 2020-08-10 | $3.48M derived: sum of 3 quarters · filed 2020-08-10 | $4.29M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-05-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $2.83M derived: sum of 2 quarters · filed 2020-08-10 | $3.64M derived: sum of 3 quarters · filed 2020-08-10 | $4.29M 10-K · filed 2020-08-10 |
| 2018-02-28 | $1.71M 10-Q · filed 2018-04-05 | $2.52M derived: sum of 2 quarters · filed 2018-04-05 | $3.17M 10-Q · filed 2018-04-05 | |
| 2017-11-30 | $812.00K 10-Q · filed 2018-01-05 | $1.46M 10-Q · filed 2018-01-05 | ||
| 2017-08-31 | $647.00K 10-Q · filed 2017-09-29 | |||
| 2017-05-31 | $278.00K 10-K · filed 2019-07-25 | |||
| 2017-02-28 | $0.00 10-Q · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |